Clinical Study
Increased Nitric Oxide and Attenuated Diastolic Blood Pressure Variability in African Americans with Mildly Impaired Renal Function
Table 3
Univariate regression analyses predicting GFR.
| Variable | β | P Value |
| Age (years) | −0.276 | NS | Male Gender | 0.005 | NS | Med. Taper | −0.282 | NS | BMI (kg/m2) | 0.179 | NS | Fat Free Mass (kg) | 0.091 | NS | Fat Mass (kg) | 0.124 | NS | Total Cholesterol (mg/dL) | −0.306 | NS | LDL Cholesterol (mg/dL) | −0.152 | NS | HDL Cholesterol (mg/dL) | −0.185 | NS | Triglycerides (mg/dL) | −0.252 | NS | Glucose (mg/dL) | 0.068 | NS | Awake SBP (mmHg) | −0.038 | NS | Sleep SBP (mmHg) | −0.005 | NS | 24-hr SBP (mmHg) | 0.023 | NS | Awake DBP (mmHg) | 0.131 | NS | Sleep DBP (mmHg) | 0.154 | NS | 24-hr DBP (mmHg) | 0.213 | NS | Awake MAP (mmHg) | 0.052 | NS | Sleep MAP (mmHg) | 0.120 | NS | 24-hr MAP (mmHg) | 0.145 | NS | Awake Systolic BPV (mmHg) | 0.133 | NS | Sleep Systolic BPV (mmHg) | 0.169 | NS | 24-hr Systolic BPV (mmHg) | 0.199 | NS | Awake Rate of SBP Variation (mmHg/min) | 0.114 | NS | Sleep Rate of SBP Variation (mmHg/min) | 0.135 | NS | 24-hr Rate of SBP Variation (mmHg/min) | 0.153 | NS | Awake Diastolic BPV (mmHg) | 0.549 | <.001 | Sleep Diastolic BPV (mmHg) | 0.240 | NS | 24-hr Diastolic BPV (mmHg) | 0.524 | .001 | Awake Rate of DBP Variation (mmHg/min) | 0.573 | <.001 | Sleep Rate of DBP Variation (mmHg/min) | 0.228 | NS | 24-hr Rate of DBP Variation (mmHg/min) | 0.626 | <.001 | Awake MAPV (mmHg) | 0.357 | .033 | Sleep MAPV (mmHg) | 0.164 | NS | 24-hr MAPV (mmHg) | 0.431 | .008 | Awake Rate of MAP Variation (mmHg/min) | 0.342 | .041 | Sleep Rate of MAP Variation (mmHg/min) | 0.163 | NS | 24-hr Rate of MAP Variation (mmHg/min) | 0.383 | .014 |
|
|
BMI, body mass index; BPV, blood pressure variability; DBP, diastolic blood pressure; GFR, glomerular filtration rate; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MAP, mean arterial pressure, MAPV, mean arterial pressure variability; NS, nonsignificant; SBP, systolic blood pressure.
|